Search company, investor...

Pola Pharma

pola-pharma.co.jp

Founded Year

2007

Stage

Acquired | Acquired

Valuation

$0000 

About Pola Pharma

Pola Pharma is a Japanese dermatologic cosmetics company.

Headquarters Location

Japan

Missing: Pola Pharma's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Pola Pharma's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Pola Pharma Patents

Pola Pharma has filed 26 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/10/2014

10/5/2021

Dosage forms, Colloidal chemistry, Drug delivery devices, Surfactants, Antiseptics

Grant

Application Date

7/10/2014

Grant Date

10/5/2021

Title

Related Topics

Dosage forms, Colloidal chemistry, Drug delivery devices, Surfactants, Antiseptics

Status

Grant

Latest Pola Pharma News

Sun Pharma acquires Japan’s Pola Pharma

Jan 3, 2019

Photo: Bloomberg New Delhi: Drug major Sun Pharma on Thursday said it has completed acquisition of Japan-based Pola Pharma to strengthen its presence in dermatology segment across the globe. The acquisition of 100% shares of Pola Pharma Inc Japan by the company’s wholly owned subsidiary has been concluded, Sun Pharma said in a BSE filing. Sun Pharma had entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale and distribution of branded, and generic products in Japan, it said in a regulatory filing dated 26 November 2018. Pola Pharma’s portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables, it added. Sun Pharma had forayed into the Japanese prescription market in 2016 with the acquisition of 14 established prescription brands from Novartis. Shares of Sun Pharmaceutical closed at Rs 435.35 per scrip on the BSE, down 1.12 % from its previous close. First Published: Thu, Jan 03 2019. 06 00 PM IST

Pola Pharma Frequently Asked Questions (FAQ)

  • When was Pola Pharma founded?

    Pola Pharma was founded in 2007.

  • What is Pola Pharma's latest funding round?

    Pola Pharma's latest funding round is Acquired.

  • Who are the investors of Pola Pharma?

    Investors of Pola Pharma include Sun Pharma.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.